Secondary Logo

Journal Logo

October 2017 - Volume 40 - Issue 8
pp: 289-314

Immunologic Response Elicited in Breast Cancer Patients Receiving a NeuGcGM3-based Vaccine as Adjuvant Therapy

Valdes-Zayas, Anet; Gonzalez, Zuyen; Mulens, Vladimir; More

Journal of Immunotherapy. 40(8):289-301, October 2017.

First-in-Human Treatment With a Dendritic Cell-targeting Lentiviral Vector-expressing NY-ESO-1, LV305, Induces Deep, Durable Response in Refractory Metastatic Synovial Sarcoma Patient

Pollack, Seth M.; Lu, Hailing; Gnjatic, Sacha; More

Journal of Immunotherapy. 40(8):302-306, October 2017.